| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |